Valuation: Medistim ASA

Market Cap 5.45B 587M 523M 480M 436M 820M 55.51B 839M 5.74B 2.3B 29.38B 2.2B 2.16B 93.07B P/E 2026 *
28.9x
P/E 2027 * 24.6x
Enterprise Value 5.32B 573M 511M 468M 426M 800M 54.17B 819M 5.6B 2.24B 28.67B 2.15B 2.11B 90.82B EV / Sales 2026 *
6.4x
EV / Sales 2027 * 5.69x
Free-Float
69.57%
Yield 2026 *
3.44%
Yield 2027 * 3.61%
1 day-1.00%
1 week-2.61%
Current month-2.30%
1 month+19.20%
3 months+31.86%
6 months+32.44%
Current year+15.06%
1 week 295
Extreme 295
310
1 month 250
Extreme 250
316
Current year 186.5
Extreme 186.5
316
1 year 186.5
Extreme 186.5
316
3 years 130
Extreme 130
316
5 years 130
Extreme 130
402.5
10 years 60
Extreme 60
409
Manager TitleAgeSince
Chief Executive Officer 62 31/08/2009
Director of Finance/CFO - 31/12/2000
Chief Tech/Sci/R&D Officer - 31/12/2024
Director TitleAgeSince
Chairman 78 31/12/1999
Director/Board Member 56 31/03/2023
Director/Board Member 46 -
Date Insider Type Main position Quantity % Market Cap. Importance
04/03/25 Buy

Chairman

860,735 4.6939%
27/01/25 Buy

Chairman

45,000 0.2454%
09/01/25 Buy

Chairman

30,000 0.1636%
Change 5-day change 1-year change 3-year change Capi.($)
-1.00%-2.61%+10.78%+37.96% 593M
+1.12%+1.90%+25.01%+55.29% 259B
+2.09%+1.26%+9.75%+18.73% 162B
+9.38%+8.12%-11.41%+73.09% 153B
+5.33%+1.69%-53.52%-12.77% 63.04B
+3.46%+7.12%-8.13%-6.52% 54.01B
+4.39%+9.41%+19.62%+48.16% 54.87B
+2.45%-0.90%+6.12%+59.63% 49.09B
+0.97%-0.18%+22.45%+62.51% 49.47B
+1.67%-0.20%+35.30%+79.51% 45.18B
Average +1.23%-0.74%+5.60%+41.56% 88.97B
Weighted average by Cap. +0.88%-0.55%+7.40%+44.54%

Financials

2026 *2027 *
Net sales 831M 89.54M 79.79M 73.17M 66.49M 125M 8.46B 128M 875M 351M 4.48B 336M 329M 14.19B 938M 101M 90.06M 82.59M 75.06M 141M 9.55B 144M 987M 396M 5.06B 379M 371M 16.01B
Net income 189M 20.36M 18.15M 16.64M 15.12M 28.43M 1.92B 29.08M 199M 79.73M 1.02B 76.44M 74.8M 3.23B 221M 23.81M 21.22M 19.46M 17.68M 33.24M 2.25B 34M 233M 93.23M 1.19B 89.38M 87.47M 3.77B
Net Debt -132M -14.17M -12.63M -11.58M -10.52M -19.78M -1.34B -20.23M -138M -55.48M -709M -53.18M -52.04M -2.25B -118M -12.66M -11.28M -10.35M -9.4M -17.67M -1.2B -18.08M -124M -49.57M -633M -47.52M -46.5M -2.01B
Projected Income Statement - Annual - Medistim ASA
Logo Medistim ASA
Medistim ASA is a Norway-based company engaged in the provision of medical equipment and technology. It develops, manufactures and distributes medical devices that measure blood flow and visualize atherosclerosis, and thereby help improve the outcome of cardiac and vascular surgery. The Company provides Transit Time Flow Measurement (TTFM) and ultrasound imaging to the global market to enable medical professionals to reduce risk and enhance quality of cardiac, vascular and transplant surgery. Medistim’s activities are divided into two business units: Own Products Category and Third-Party Products Category. Furthermore, the Company has several subsidiaries, including Medistim USA Inc, Medistim Norge AS and Medistim Japan KK.
Employees
159
Date Price Change Volume
04/11/26 NOK 298.00 -1.00% 14,306
03/11/26 NOK 301.00 -1.95% 7,924
02/11/26 NOK 307.00 +0.66% 8,289
30/10/26 NOK 305.00 -0.65% 8,719
29/10/26 NOK 307.00 -0.32% 9,162
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Medistim ASA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
298.00NOK
Average target price
365.00NOK
Spread / Average Target
+22.48%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Medistim ASA
  1. Stock Market
  2. Stocks
  3. MEDI Stock